期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
胆红素吸附治疗高胆红素血症的疗效分析 被引量:15
1
作者 曾湘丽 肖平 +4 位作者 周巧玲 袁琼婧 李霞 陈豫萨 肖湘成 《中国现代医学杂志》 CAS 2019年第3期110-113,共4页
目的观察高胆红素血症患者行胆红素吸附治疗的临床疗效。方法选取2015—2017年在中南大学湘雅医院血液净化中心行胆红素吸附治疗的高胆红素血症患者,共10例。其中,男性8例,女性2例;平均年龄(57±18)岁。结果 10例患者共行18次胆红... 目的观察高胆红素血症患者行胆红素吸附治疗的临床疗效。方法选取2015—2017年在中南大学湘雅医院血液净化中心行胆红素吸附治疗的高胆红素血症患者,共10例。其中,男性8例,女性2例;平均年龄(57±18)岁。结果 10例患者共行18次胆红素吸附治疗,其中显效1例,有效8例,无效2例,总有效率为80%。治疗后胆红素降低(P <0.05),对转氨酶、肌酐、尿素、尿酸的清除无作用(P>0.05),对白蛋白、血常规、凝血常规、E7A无影响(P>0.05)。结论胆红素吸附在治疗以血清胆红素升高为主的高胆红素血症患者效果较好,安全性高。若合并有自发性腹膜炎、肝肾综合征、肝性脑病等并发症的危重患者,则应联合多种人工肝治疗模式。 展开更多
关键词 高胆红素血症 肝功能衰竭 急性 胆红素吸附治疗 并发症
下载PDF
Involvement of hydrogen sulfide in the progression of renal fibrosis 被引量:5
2
作者 Yu Wang Qi-Qi Xing +11 位作者 Jing-Ke Tu Wen-Bin Tang Xiang-Ning yuan Yan-Yun Xie Wei Wang Zhang-Zhe Peng Ling Huang Hui Xu Jiao Qin Xiang-Cheng Xiao Li-Jian Tao qiong-jing yuan 《Chinese Medical Journal》 SCIE CAS CSCD 2019年第23期2872-2880,共9页
Objective:Renal fibrosis is the most common manifestation of chronic kidney disease(CKD).Noting that existing treatments of renal fibrosis only slow disease progression but do not cure it,there is an urgent need to id... Objective:Renal fibrosis is the most common manifestation of chronic kidney disease(CKD).Noting that existing treatments of renal fibrosis only slow disease progression but do not cure it,there is an urgent need to identify novel therapies.Hydrogen sulfide(H2S)is a newly discovered endogenous small gas signaling molecule exerting a wide range of biologic actions in our body.This review illustrates recent experimental findings on the mechanisms underlying the therapeutic effects of H2S against renal fibrosis and highlights its potential in future clinical application.Data sources:Literature was collected from PubMed until February 2019,using the search terms including"Hydrogen sulfide,""Chronic kidney disease"MRenal interstitial fibrosis,"Kidney disease,""Inflammation factor,""Oxidative stress,""Epithelialto-mesenchymal transition,""H2S donor,""Hypertensive kidney dysfunction,""Myofibroblasts,""Vascular remodeling,""transforming growth factor(TGF)-beta/Smads signaling,"and"Sulfate potassium channels."Study selection:Literature was mainly derived from English articles or articles that could be obtained with English abstracts.Article type was not limited.References were also identified from the bibliographies of identified articles and the authors5 files.Results:The experimental data confirmed that H2S is widely involved in various renal pathologies by suppressing inflammation and oxidative stress,inhibiting the activation of fibrosis-related cells and their cytokine expression,ameliorating vascular remodeling and high blood pressure,stimulating tubular cell regeneration,as well as reducing apoptosis,autophagy,and hypertrophy.Therefore,H2S represents an alternative or additional therapeutic approach for renal fibrosis.Conclusions:We postulate that H2S may delay the occurrence and progress of renal fibrosis,thus protecting renal function.Further experiments are required to explore the precise role of H2S in renal fibrosis and its application in clinical treatment. 展开更多
关键词 Hydrogen sulfide Renal interstitial fibrosis Chronic kidney disease
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部